A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major medical society recommends the test for screening.

Chair of powerful parliamentary committee writes to Health Secretary Wes Streeting backing Mirror campaign and demanding action on spinal muscular atrophy (SMA) ...

Comprehensive biomarker testing is crucial for NSCLC treatment, yet disparities exist between academic and community settings ...

Person-to-person transmissions of hepatitis A have occurred across the United States and many are affecting gay and bisexual men. Hepatitis A outbreaks among MSM have been reported frequently despite ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

The Director of the National Centre of Excellence for Sickle Cell Disease Research and Training, Prof. Obiageli Nnodu, said ...

Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.

For nearly a decade, Rohit spent his childhood in hospital wards instead of playgrounds. Diagnosed with beta thalassemia major at just six months of age, he nee ...

In a significant move towards enhancing cancer detection and treatment, telehealth company Hims & Hers has announced the addition of Grail's Galleri multi-cancer blood test to its extensive digital ...